320350-04-7

Upstream product

• 213385-74-1 7,8-dimethoxy-1-(4-nitro-phenyl)-3,5-dihydro-benzo[d][1,2]diazepine-4-thione 
• 4114-31-2 ethylhydrazine carboxylate 
• 555-16-8 4-nitrobenzaldehdye 
• 92774-40-8 3,4-dihydro-6,7-dimethoxy-1-(4-nitrophenyl)-1H-isochromene 
• 7417-21-2 2-(3,4-dimethoxyphenyl)ethyl alcohol 
• 187940-12-1 7,8-Dimethoxy-1-(4-nitro-phenyl)-3,5-dihydro-benzo[d][1,2]diazepin-4-one 
• 187940-06-3 [4,5-Dimethoxy-2-(4-nitro-benzoyl)-phenyl]-acetic acid 

Relevant academic research and scientific papers

Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones

A series of 2,3-benzodiazepine derivatives has been previously described as noncompetitive AMPA-type glutamate receptor antagonists potentially useful for treatment of epilepsy. To further explore the structure-activity relationships of AMPA antagonists,

Design and development of 2,3-benzodiazepine (CFM) noncompetitive AMPA receptor antagonists

2,3-Benzodiazepines represent a class of heterocyclic compounds that interact with AMPA-type glutamate receptors in a noncompetitive manner. These compounds have attracted great interest for their pharmacological effects against acute and chronic neurodeg